Cutler Group LP Abb Vie Inc. Put Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Put Options

25 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Jan 18, 2024	BUY	$137.6 - $154.97 $151,360 - $170,467	1,100 Added 7.59%	15,600 $9,000
Q3 2023 Nov 07, 2023	SELL	$133.59 - $154.65 $53,436 - $61,860	-400 Reduced 2.68%	14,500 $86,000
Q2 2023 Jul 18, 2023	BUY	$132.51 - $164.9 $1.86 Million - $2.31 Million	14,000 Added 1555.56%	14,900 $127,000
Q1 2023 May 01, 2023	SELL	$144.61 - $166.54 $4.61 Million - $5.31 Million	-31,900 Reduced 97.26%	900 $5,000
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $567,071 - $680,067	-4,100 Reduced 11.11%	32,800 $54,000
Q3 2022 Oct 25, 2022	SELL	$134.21 - $153.93 $6.25 Million - $7.17 Million	-46,600 Reduced 55.81%	36,900 $295,000
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $13.4 Million - $17 Million	-97,300 Reduced 53.82%	83,500 $146,000
Q1 2022 Apr 14, 2022	BUY	$131.98 - $163.75 $15.1 Million - $18.7 Million	114,100 Added 171.06%	180,800 $168,000
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $1.07 Million - $1.36 Million	10,000 Added 17.64%	66,700 $45,000
Q3 2021 Oct 26, 2021	SELL	$106.4 - $120.78 $13.3 Million - $15.1 Million	-125,100 Reduced 68.81%	56,700 $251,000
Q2 2021 Jul 19, 2021	BUY	$105.21 - $117.21 $15.7 Million - $17.5 Million	149,200 Added 457.67%	181,800 $53,000
Q1 2021 Apr 26, 2021	SELL	$102.3 - $112.62 $3.83 Million - $4.21 Million	-37,400 Reduced 53.43%	32,600 $26,000
Q4 2020 Jan 21, 2021	BUY	$80.49 - $108.67 $5.25 Million - $7.09 Million	65,200 Added 1358.33%	70,000 $61,000
Q3 2020 Oct 27, 2020	SELL	$85.91 - $100.83 $206,184 - $241,992	-2,400 Reduced 33.33%	4,800 $24,000
Q2 2020 Jul 22, 2020	SELL	$73.37 - $98.18 $1.21 Million - $1.62 Million	-16,500 Reduced 69.62%	7,200 $31,000
Q1 2020 May 07, 2020	BUY	$64.5 - $97.79 $554,700 - $840,994	8,600 Added 56.95%	23,700 $221,000
Q4 2019 Feb 06, 2020	SELL	$72.13 - $90.25 $324,585 - $406,125	-4,500 Reduced 22.96%	15,100 $75,000
Q3 2019 Oct 28, 2019	SELL	$62.98 - $75.72 $346,390 - $416,460	-5,500 Reduced 21.91%	19,600 $194,000
Q2 2019 Aug 09, 2019	BUY	$65.7 - $83.98 $538,740 - $688,636	8,200 Added 48.52%	25,100 $252,000
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $910,252 - $1.07 Million	11,800 Added 231.37%	16,900 $60,000
Q3 2018 Nov 07, 2018	SELL	$88.91 - $98.84 $1.3 Million - $1.44 Million	-14,600 Reduced 74.11%	5,100 $1,000
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $134,670 - $159,345	-1,500 Reduced 7.08%	19,700 $49,000
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $1.15 Million - $1.54 Million	-12,500 Reduced 37.09%	21,200 $71,000
Q4 2017 Jan 17, 2018	SELL	$89.56 - $98.21 $403,020 - $441,945	-4,500 Reduced 11.78%	33,700 $11,000
Q3 2017 Oct 17, 2017	BUY	$69.85 - $89.22 $2.67 Million - $3.41 Million	38,200	38,200 $25,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account